TKNOライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:31):

Stats
本日の出来高	9 205.00
平均出来高	12 920.00
時価総額	71.44M
EPS	$0 ( 2024-03-11 )
次の収益日	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.510
ATR14	$0.0380 (2.17%)

Insider Trading

Date	Person	Action	Amount	type
2022-08-16	Grossman Paul David	Buy	4 386	Common Stock
2022-08-15	Grossman Paul David	Buy	4 826	Common Stock
2023-08-31	Mcnamara Robert	Sell	12 292	Non-Qualified Stock Option (right to buy)
2023-06-02	Mcnamara Robert	Buy	18 815	Common Stock
2023-08-31	Mcnamara Robert	Sell	18 815	Common Stock

INSIDER POWER
97.74
Last 82 transactions
Buy: 28 174 863 \| Sell: 2 326 861

Alpha Teknova, Inc. 相関

10 最も正の相関
AGNCM	0.863
BRKH	0.861
DOOO	0.859
CMTL	0.859
BTAI	0.841
FLL	0.835
CVCY	0.834
CLGN	0.828
EUSG	0.825
EUFN	0.815

10 最も負の相関
CMLF	-0.809

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Alpha Teknova, Inc. 財務諸表

Annual	2023
収益:	$36.68M
総利益:	$9.15M (24.94 %)
EPS:	$-1.160

FY	2023
収益:	$36.68M
総利益:	$9.15M (24.94 %)
EPS:	$-1.160

FY	2022
収益:	$41.42M
総利益:	$17.48M (42.19 %)
EPS:	$-1.690

FY	2021
収益:	$36.89M
総利益:	$17.62M (47.76 %)
EPS:	$-0.464

Financial Reports:

No articles found.

Alpha Teknova, Inc.

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.